Biosimilars: Creating Workable Solutions To Global Regulatory And Analytical Challenges

Global manufacturers are exploring the possibility of producing Biosimilars or follow-on biologics to extend product pipelines and increase availability of lower cost products. As biopharmaceuticals are large, complex molecules manufacturing changes may alter clinical efficacy and safety of the biologic product, complicating their development.

This webinar will explore the current regulatory and scientific challenges facing industry engaged in developing Biosimilars with emphasis on EU and US regulatory framework.

Click here to view the webinar